What are the potential benefits and risks of participating in this trial?

This is a question you may want to discuss with your doctor regarding the Phase III Trial of Sirolimus in IBM clinical trial (NCT04789070). Contact the study team or your healthcare provider for specific answers.

How does Sirolimus compare to other treatments I might consider for my IBM?

This is a question you may want to discuss with your doctor regarding the Phase III Trial of Sirolimus in IBM clinical trial (NCT04789070). Contact the study team or your healthcare provider for specific answers.

What will the study visits involve, and how often will I need to come in?

This is a question you may want to discuss with your doctor regarding the Phase III Trial of Sirolimus in IBM clinical trial (NCT04789070). Contact the study team or your healthcare provider for specific answers.

Are there any specific side effects I should be aware of with Sirolimus?

This is a question you may want to discuss with your doctor regarding the Phase III Trial of Sirolimus in IBM clinical trial (NCT04789070). Contact the study team or your healthcare provider for specific answers.

How will my progress be monitored during the trial?

This is a question you may want to discuss with your doctor regarding the Phase III Trial of Sirolimus in IBM clinical trial (NCT04789070). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

Phase III Trial of Sirolimus in IBM

NCT0478907010 sitesClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Phase III Trial of Sirolimus in IBM